Multisystem inflammatory syndrome associated with COVID-19 in adult: the case report

Abstract

The multisystem inflammatory syndrome associated with COVID-19 coronavirus infection was first described in April-May 2020, mainly among children who had an acute infectious disease. Soon there were reports of the development of MIS in adults (MIS-A). More than 200 cases of MVS in adults have been described and systematized in the world, while in Russia there is no separate registration of MVS, a single description of MVS is given in the literature.

Material and methods. We presented Case report of MIS-A in a 21-year-old woman, accompanied by persistent fever, multiple organ failure syndrome, is presented. The stages of diagnosis and treatment of MIS-A.

Result and discussion. A positive effect was achieved during therapy with corticosteroids and intravenous immunoglobulin. MIS-A is a rare life-threatening complication of a COVID-19 that requires emergency therapy with the inclusion of corticosteroids and intravenous immunoglobulin in an adequate dose. The given example will be interesting for general practitioners, infectious disease specialists and therapists.

Keywords:COVID-19; MIS-A; adults; intensive care

Funding. This study did not receive any funding.

Conflict of interest. The authors declare no conflict of interest.

Contribution. The concept and design of the study – Belyaletdinova I.Kh., Sayfullin M.A.; collection of material – Guseva G.D., Perekopskaya N.E.; material processing, statistical data processing, writing the text of the article – Belyaletdinova I.Kh., Sayfullin M.A.; editing – Sayfullin M.A., Guseva G.D.; approval of the final version of the article – Belyaletdinova I.Kh., Saifullin M.A.; responsibility for the integrity of all parts of the article – Belyaletdinova I.Kh., Saifullin M.A.

For citation: Belyaletdinova I.Kh., Sayfullin M.A., Guseva G.D., Perekopskaya N.E. Multisystem inflammatory syndrome associated with COVID-19 in adult: the case report. Infektsionnye bolezni: novosti, mneniya, obuchenie [Infectious Diseases: News, Opinions, Training]. 2023; 12 (1): 123–7. DOI: https://doi.org/10.33029/2305-3496-2023-12-1-123–7 (in Russian)

References

1. Riphagen S., Gomez X., Gonzalez-Martinez C., Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020; 395 (10 237): 1607–8.

2. DeBiasi R.L., Song X., Delaney M., Bell M., Smith K., Pershad J., et al. Severe coronavirus disease-2019 in children and young adults in the Washington, DC, Metropolitan Region. J Pediatr. 2020; 223: 199–203.e1. DOI: https://doi.org/10.1016/j.jpeds.2020.05.007

3. Jones V.G., Mills M., Suarez D., Hogan C.A., Yeh D., Bradley Segal J., et al. COVID-19 and Kawasaki disease: Novel virus and novel case. Hosp Pediatr. 2020; 10 (6): 537–40.

4. WHO. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. Scientific Brief. 15 May 2020. URL: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19 (date of access March 25, 2022).

5. CDC. Multisystem Inflammatory Syndrome. URL: https://www.cdc.gov/mis/about.html (date of access March 25, 2022).

6. Interim guidelines for the prevention, diagnosis and treatment of novel coronavirus infection (COVID-19). Version 15 from 02/22/2022. URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/059/392/original/%D0%92%D0%9C%D0%A0_COVID-19_V15.pdf (date of access March 25, 2022). (in Russian)

7. Lobzin Yu.V., Vilnits A.A., Kostik M.M., Bekhtereva M.K., et al. Pediatric multisystem inflammatory syndrome associated with a new coronavirus infection: unresolved issues. Zhurnal infektologii [Journal of Infectology]. 2021; 13 (1): 13–20. DOI: https://doi.org/10.22625/2072-6732-2021-13-1-13-20 (in Russian)

8. Morris S.B., Schwartz N.G., Patel P., et al. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection – United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020; 69 (40): 1450–6. DOI: https://doi.org/10.15585/mmwr.mm6940e1

9. Patel P., DeCuir J., Abrams J., Campbell A.P., Godfred-Cato S., Belay E.D. Clinical characteristics of multisystem inflammatory syndrome in adults: A systematic review. JAMA Netw Open. 2021; 4 (9): e2126456. DOI: https://doi.org/10.1001/jamanetworkopen.2021.26456

10. Chamsutdinov N.U., Abdulmanapova D.N. Multisystem inflammatory syndrome in a patient with COVID-19: a case from the practice of a therapist. Vestnik Dagestanskoy gosudarstvennoy meditsinskoy akademii [Bulletin of the Dagestan State Medical Academy]. 2021; 1 (38): 47–54. URL: http://vestnikdgma.ru/sites/default/files/vestnik_dgma_no1382021_1_2_3.pdf (date of access March 25, 2022) (in Russian)

11. Carter M.J., Fish M., Jennings A., Doores K.J., Wellman P., Seow J., et al. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Nat Med. 2020; 26: 1701–7.

12. Nakra N.A., Blumberg D.A., Herrera-Guerra A., Lakshminrusimha S. Multi-system inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management. Children (Basel). 2020; 7: 69.

13. Riphagen S., Gomez X., Gonzalez-Martinez C., Wilkinson N., Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020; 395: 1607–8.

14. Feldstein L.R., Rose E.B., Horwitz S.M., Collins J.P., Newhams M.M., Son M.B.F., et al.; CDC COVID-19 Response Team. Multisystem inflammatory syndrome in US children and adolescents. N Engl J Med. 2020; 383: 334–46.

15. Godfred-Cato S., Bryant B., Leung J., Oster M.E., Conklin L., Abrams J., et al.; California MIS-C Response Team. COVID-19-associated multisystem inflammatory syndrome in children – United States, March–July 2020. MMWR Morb Mortal Wkly Rep. 2020; 69: 1074–80.

16. Davies P., Evans C., Kanthimathinathan H.K., Lillie J., Brierley J., Waters G., et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health. 2020; 4: 669–77.

17. Lee P.Y., Day-Lewis M., Henderson L.A., Friedman K.G., Lo J., Roberts J.E., et al. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020; 130: 5942–50.

18. National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines. Updated August 4, 2021. Accessed January 7, 2021.

19. Pombo F., Seabra C., Soares V., Sá A.J., Ferreira I., Mendes M. COVID-19-related multisystem inflammatory syndrome in a young adult. Eur J Case Rep Intern Med. 2021; 8 (4): 002520. DOI: https://doi.org/10.12890/2021_002520

20. Amato M.K., Hennessy C., Shah K., Mayer J. Multisystem inflammatory syndrome in an adult. J Emerg Med. 2021; 61 (1): e1–3. DOI: https://doi.org/10.1016/j.jemermed.2021.02.007

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
Aleksandr V. Gorelov
Academician of the Russian Academy of Sciences, MD, Head of Infection Diseases and Epidemiology Department of the Scientific and Educational Institute of Clinical Medicine named after N.A. Semashko ofRussian University of Medicine, Ministry of Health of the Russian Federation, Professor of the Department of Childhood Diseases, Clinical Institute of Children's Health named after N.F. Filatov, Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Deputy Director for Research, Central Research Institute of Epidemiology, Rospotrebnadzor (Moscow, Russian Federation)

Journals of «GEOTAR-Media»